Literature DB >> 22560808

Late effects in adult survivors of pediatric cancer: a guide for the primary care physician.

Lisa M Kopp1, Puja Gupta, Luz Pelayo-Katsanis, Brenda Wittman, Emmanuel Katsanis.   

Abstract

Because of significant medical advances in the past 50 years, the number of adult survivors of childhood/adolescent cancer has increased dramatically. Unfortunately, more than 60% of these survivors will have at least 1 long-term side effect from treatment. This growing population requires dedicated care by their primary physicians because they have specific risk factors depending on their initial cancer diagnosis and the treatment modalities they received. Internists and family physicians play an integral role in providing appropriate screening, treatment, and counseling to prevent morbidity and mortality in these patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22560808     DOI: 10.1016/j.amjmed.2012.01.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.

Authors:  Dana L Casey; Leonard H Wexler; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-30       Impact factor: 7.038

2.  Salivary gland second cancer after bone sarcoma treatment.

Authors:  Alessandra Longhi; Costantino Errani; Marco Gambarotti; Christina Ferrari; Jennifer Kreshak; Georgios N Panagopoulos; Andreas F Mavrogenis; Davide Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-07-15

3.  New role for the mitochondrial peptide humanin: protective agent against chemotherapy-induced side effects.

Authors:  Pinchas Cohen
Journal:  J Natl Cancer Inst       Date:  2014-03-01       Impact factor: 13.506

4.  Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.

Authors:  Stephanie L Nassar; Heather M Conklin; Yinmei Zhou; Jason M Ashford; Wilburn E Reddick; John O Glass; Fred H Laningham; Sima Jeha; Cheng Cheng; Ching-Hon Pui
Journal:  Pediatr Blood Cancer       Date:  2017-01-28       Impact factor: 3.167

5.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

6.  Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine.

Authors:  Galán-Gómez Víctor; Matamala Nerea; Ruz-Caracuel Beatriz; Valle-Simón Paula; Ochoa-Fernández Bárbara; Guerra-García Pilar; Pernas-Sánchez Alicia; Minguillón Jordi; González Berta; Martínez-Romera Isabel; San Román-Pacheco Sonsoles; Estival-Monteliú Pablo; Ibáñez-Navarro Adrián; Pérez-Martínez Antonio; Escudero-López Adela
Journal:  J Pers Med       Date:  2022-05-27

7.  The Potent Humanin Analogue (HNG) Protects Germ Cells and Leucocytes While Enhancing Chemotherapy-Induced Suppression of Cancer Metastases in Male Mice.

Authors:  YanHe Lue; Ronald Swerdloff; Junxiang Wan; Jialin Xiao; Samuel French; Vince Atienza; Victor Canela; Kevin W Bruhn; Brian Stone; Yue Jia; Pinchas Cohen; Christina Wang
Journal:  Endocrinology       Date:  2015-09-18       Impact factor: 4.736

8.  Late bone and soft tissue sequelae of childhood radiotherapy. Relevance of treatment age and radiation dose in 146 children treated between 1970 and 1997.

Authors:  W Dörr; S Kallfels; T Herrmann
Journal:  Strahlenther Onkol       Date:  2013-05-25       Impact factor: 3.621

9.  The landscape of genomic alterations across childhood cancers.

Authors:  Susanne N Gröbner; Barbara C Worst; Joachim Weischenfeldt; Ivo Buchhalter; Kortine Kleinheinz; Vasilisa A Rudneva; Pascal D Johann; Gnana Prakash Balasubramanian; Maia Segura-Wang; Sebastian Brabetz; Sebastian Bender; Barbara Hutter; Dominik Sturm; Elke Pfaff; Daniel Hübschmann; Gideon Zipprich; Michael Heinold; Jürgen Eils; Christian Lawerenz; Serap Erkek; Sander Lambo; Sebastian Waszak; Claudia Blattmann; Arndt Borkhardt; Michaela Kuhlen; Angelika Eggert; Simone Fulda; Manfred Gessler; Jenny Wegert; Roland Kappler; Daniel Baumhoer; Stefan Burdach; Renate Kirschner-Schwabe; Udo Kontny; Andreas E Kulozik; Dietmar Lohmann; Simone Hettmer; Cornelia Eckert; Stefan Bielack; Michaela Nathrath; Charlotte Niemeyer; Günther H Richter; Johannes Schulte; Reiner Siebert; Frank Westermann; Jan J Molenaar; Gilles Vassal; Hendrik Witt; Birgit Burkhardt; Christian P Kratz; Olaf Witt; Cornelis M van Tilburg; Christof M Kramm; Gudrun Fleischhack; Uta Dirksen; Stefan Rutkowski; Michael Frühwald; Katja von Hoff; Stephan Wolf; Thomas Klingebiel; Ewa Koscielniak; Pablo Landgraf; Jan Koster; Adam C Resnick; Jinghui Zhang; Yanling Liu; Xin Zhou; Angela J Waanders; Danny A Zwijnenburg; Pichai Raman; Benedikt Brors; Ursula D Weber; Paul A Northcott; Kristian W Pajtler; Marcel Kool; Rosario M Piro; Jan O Korbel; Matthias Schlesner; Roland Eils; David T W Jones; Peter Lichter; Lukas Chavez; Marc Zapatka; Stefan M Pfister
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

10.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.